Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2005, p. 1437-1438, Vol. 43, No. 3
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.3.1437-1438.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
IMTSSA, WHO Collaborating Centre for Reference and Research on Meningococci, le Pharo, Marseille, France,1 CERMES, Ministry of Health, Réseau International des Instituts Pasteur, Niamey, Niger2
Received 12 August 2004/ Returned for modification 21 September 2004/ Accepted 16 November 2004
In 2003, in the Zinder and Maradi regions (Niger), epidemics were due to serogroup A:4:P1.9 meningococci belonging to sequence type 7 (ST-7). In Niamey, only sporadic cases were reported: 55% of the meningococcus strains were in serogroup A, and 38% were in serogroup W135 and could be placed in ST-11, identical to the 2002 Burkina Faso epidemic clone, and in ST-2881, a new ST.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|